日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/05/08 | 4,540 | 4,695 | 4,540 | 4,655 | +135 | +3% | 3,600 |
| 2018/05/07 | 4,580 | 4,615 | 4,515 | 4,520 | -85 | -1.8% | 2,200 |
| 2018/05/02 | 4,540 | 4,605 | 4,540 | 4,605 | +20 | +0.4% | 600 |
| 2018/05/01 | 4,570 | 4,630 | 4,570 | 4,585 | -45 | -1% | 600 |
| 2018/04/27 | 4,625 | 4,640 | 4,555 | 4,630 | -40 | -0.9% | 2,600 |
| 2018/04/26 | 4,560 | 4,670 | 4,530 | 4,670 | +105 | +2.3% | 2,400 |
| 2018/04/25 | 4,505 | 4,580 | 4,505 | 4,565 | +30 | +0.7% | 6,500 |
| 2018/04/24 | 4,510 | 4,565 | 4,500 | 4,535 | +25 | +0.6% | 2,300 |
| 2018/04/23 | 4,525 | 4,530 | 4,490 | 4,510 | -85 | -1.8% | 5,900 |
| 2018/04/20 | 4,595 | 4,600 | 4,590 | 4,595 | -55 | -1.2% | 1,100 |
| 2018/04/19 | 4,615 | 4,740 | 4,590 | 4,650 | +50 | +1.1% | 2,100 |
| 2018/04/18 | 4,585 | 4,690 | 4,585 | 4,600 | -15 | -0.3% | 1,200 |
| 2018/04/17 | 4,675 | 4,675 | 4,610 | 4,615 | -105 | -2.2% | 1,300 |
| 2018/04/16 | 4,800 | 4,800 | 4,680 | 4,720 | -80 | -1.7% | 1,100 |
| 2018/04/13 | 4,830 | 4,830 | 4,765 | 4,800 | -10 | -0.2% | 1,400 |
| 2018/04/12 | 4,770 | 4,810 | 4,755 | 4,810 | +25 | +0.5% | 700 |
| 2018/04/11 | 4,825 | 4,830 | 4,785 | 4,785 | +25 | +0.5% | 1,200 |
| 2018/04/10 | 4,800 | 4,800 | 4,745 | 4,760 | -10 | -0.2% | 300 |
| 2018/04/09 | 4,830 | 4,830 | 4,770 | 4,770 | -25 | -0.5% | 300 |
| 2018/04/06 | 4,800 | 4,800 | 4,775 | 4,795 | +5 | +0.1% | 2,600 |
| 2018/04/05 | 4,820 | 4,820 | 4,790 | 4,790 | +30 | +0.6% | 500 |
| 2018/04/04 | 4,630 | 4,765 | 4,630 | 4,760 | +135 | +2.9% | 1,500 |
| 2018/04/03 | 4,650 | 4,800 | 4,625 | 4,625 | -35 | -0.8% | 1,900 |
| 2018/04/02 | 4,665 | 4,665 | 4,660 | 4,660 | -65 | -1.4% | 300 |
| 2018/03/30 | 4,795 | 4,820 | 4,720 | 4,725 | +60 | +1.3% | 2,100 |
| 2018/03/29 | 4,540 | 4,695 | 4,540 | 4,665 | +55 | +1.2% | 2,100 |
| 2018/03/28 | 4,705 | 4,705 | 4,565 | 4,610 | -195 | -4.1% | 1,100 |
| 2018/03/27 | 4,700 | 4,815 | 4,700 | 4,805 | +145 | +3.1% | 2,700 |
| 2018/03/26 | 4,555 | 4,660 | 4,555 | 4,660 | +105 | +2.3% | 2,200 |
| 2018/03/23 | 4,485 | 4,610 | 4,420 | 4,555 | -125 | -2.7% | 3,800 |
| 2018/03/22 | 4,660 | 4,700 | 4,660 | 4,680 | -50 | -1.1% | 700 |
| 2018/03/20 | 4,800 | 4,800 | 4,730 | 4,730 | -40 | -0.8% | 500 |
| 2018/03/19 | 4,735 | 4,790 | 4,735 | 4,770 | +45 | +1% | 1,100 |
| 2018/03/16 | 4,755 | 4,820 | 4,725 | 4,725 | -30 | -0.6% | 5,600 |
| 2018/03/15 | 4,785 | 4,785 | 4,755 | 4,755 | ±0 | ±0% | 1,100 |
| 2018/03/14 | 4,750 | 4,785 | 4,750 | 4,755 | -30 | -0.6% | 700 |
| 2018/03/13 | 4,735 | 4,795 | 4,665 | 4,785 | +90 | +1.9% | 2,000 |
| 2018/03/12 | 4,595 | 4,730 | 4,595 | 4,695 | +100 | +2.2% | 2,000 |
| 2018/03/09 | 4,645 | 4,645 | 4,575 | 4,595 | -70 | -1.5% | 2,200 |
| 2018/03/08 | 4,690 | 4,690 | 4,665 | 4,665 | +15 | +0.3% | 500 |
| 2018/03/07 | 4,635 | 4,705 | 4,635 | 4,650 | -55 | -1.2% | 800 |
| 2018/03/06 | 4,635 | 4,725 | 4,635 | 4,705 | +80 | +1.7% | 1,700 |
| 2018/03/05 | 4,630 | 4,645 | 4,600 | 4,625 | -60 | -1.3% | 2,100 |
| 2018/03/02 | 4,805 | 4,805 | 4,665 | 4,685 | -120 | -2.5% | 2,400 |
| 2018/03/01 | 4,765 | 4,845 | 4,750 | 4,805 | +55 | +1.2% | 4,300 |
| 2018/02/28 | 4,735 | 4,755 | 4,665 | 4,750 | +15 | +0.3% | 3,100 |
| 2018/02/27 | 4,600 | 4,745 | 4,600 | 4,735 | +150 | +3.3% | 1,800 |
| 2018/02/26 | 4,480 | 4,600 | 4,480 | 4,585 | +125 | +2.8% | 4,800 |
| 2018/02/23 | 4,405 | 4,465 | 4,405 | 4,460 | +45 | +1% | 1,500 |
| 2018/02/22 | 4,385 | 4,455 | 4,385 | 4,415 | +10 | +0.2% | 2,000 |
1601～
1650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
